MSF and TAC write to Motsoaledi re the ARV tender

Issues raised include:

  • A request that a Ministerial Task Team to assess procurement procedures begin work immediately.
  • Concerns about the wording of the ARV tender specifying that the inclusion of Fixed Dose Combinations (FDCs) will be based on economic considerations alone, given the current pricing of FDCs in South Africa’€™s private sector.
  • A reminder that not only are FDCs available in developing countries for as little as R69 (Ranbaxy), but that the benefits of FDCs far outweigh mere cost considerations.    

South Africa’€™s Department of Health (DoH) announced the ARV tender for the period of 1 January 2013 to 31 December 2014 on 5th October. The DoH outlined the details of the tender – which can be found here  –  in an open event on 10 October.


  • Health-e News

    Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews

    View all posts

Free to Share

Creative Commons License

Republish our articles for free, online or in print, under a Creative Commons license.

Stay in the loop

We see you enjoy reading our articles, subscribe now and receive our articles in your inbox.

Newsletter Subscription

Enable Notifications